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Background. Stroke is an important morbidity for low andmiddle income countries like Bangladesh. We established the first stroke
registry in Bangladesh. Methods. Data was collected from stroke patients who were admitted in Department of Neurology of
BIRDEMwith first ever stroke, aged between 30 and 90 years. Patients with intracerebral hemorrhage, subarachnoid and subdural
hemorrhage, and posttrauma features were excluded. Results.Data was gathered from 679 stroke patients. Mean age was 60.6 years.
Almost 68% of patients were male. Small vessel strokes were the most common accounting for 45.4% of all the patients followed
by large vessel getting affected in 32.5% of the cases. Only 16 (2.4%) died during treatment, and 436 (64.2%) patients had their
mRS score of 3 to 5. Age greater than 70 years was associated with poor outcome on discharge [OR 1.79 (95% CI: 1.05 to 3.06)]
adjusting for gender, duration of hospital stay, HDL, and pneumonia. Age, mRS, systolic blood pressure, urinary tract infection,
pneumonia, and stroke severity explained the Barthel score. Conclusion. Mortality was low but most of patient had moderate to
severe disability at discharge. Age, mRS, systolic blood pressure, urinary tract infection, pneumonia, and stroke severity influenced
the Barthel score.
1. Introduction
Stroke, an important morbidity in the context of sustain-
ability development goals (SDGs), is the leading cause of
disability in the Asian population [1, 2]. Low and middle
income countries have a higher burden andmortality because
of stroke and it is increasing over time [3–6]. Stroke becomes
important health problem for Bangladesh as more than 25%
of its population live below the poverty line [7]. Bangladesh
is third largest country among south Asian countries after
India and Pakistan with a population of 160 billion. South
Asian countries constitute 22% of world population and 40%
of developing world and account for more than 40% of global
stroke death [8].
A large number of preventable deaths in Bangladesh
occur due to stroke [9, 10]. Stroke ranks third among causes
of death in Bangladesh [9]. Mortality due to stroke increased
from 6% to around 9% from 2006 to 2011 [9]. Individuals
in Bangladesh having age of 40 years or more have a stroke
prevalence of 0.3% and its prevalence increases to 1% in
individuals aged 70 years or more [10]. Gender and age
are two important factors affecting stroke prevalence in
Bangladesh [10]. Risk factors for stroke in Bangladesh include
hyperlipidemia, diabetes mellitus, heart disease, cigarette
smoking, oral contraception use, and previous history of TIA
[11, 12]. Frequencies of these risk factors are comparable to
other south Asian countries [8]. The majority of the stroke
patients suffer from ischemic stroke which had a better
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prognosis as compared to the hemorrhagic stroke [13, 14].
Bangladesh due to its large population lacks the requisite
health infrastructure and trained human resource needed to
deal with the high burden of stroke [15].
World Health Organization (WHO) recommends 3-step
approach to establish stroke surveillance system. First step
should capture data about stroke in the hospital giving infor-
mation about treatment and mortality of the stroke patients.
In the subsequent steps WHO recommend capturing stroke
related fatal and nonfatal events in the community [16].
Experiences from the region have recommended establishing
a hospital based surveillance system [17]. Establishing such a
system for low and middle income countries in the commu-
nitymight be challenging because of the cost implications [17,
18]. In order to improve the quality of evidence generated it
is recommended that surveillance system using standardized
approaches be establish [16].
Studies done on stroke in Bangladesh have quantified
the prevalence of stroke but studies collected information on
limited number of the relevant variables [19]. In light of this
limitation of previous data we established stroke registry in
Bangladesh to get information on relevant and important risk
factors of stroke. The aim of this registry was to regularly
quantify burden of various types of stroke in Bangladesh
and to identify their risk factors. We intended to compare
the results from this registry to the risk factors for stroke
identified in other countries of the region like India and
Pakistan. This piece of information is critical for evidence
based resource allocation at health care centers.
2. Materials and Methods
A total number of 679 subjects with first ever stroke
consecutively admitted in the Department of Neurology
of Bangladesh Institute of Research and Rehabilitation in
Diabetes, Endocrine and Metabolic Disorders (BIRDEM)
General Hospital, were recruited for the study during January
2011 to February 2013.
Inclusion criteria were age between 30 and 90 years and
patients presenting with first ever stroke. Diagnosis of stroke
was done on the basis of findings from Neuroimaging (either
of CT or MRI). Patients with intracerebral hemorrhage,
subarachnoid and subdural hemorrhage, and posttrauma
features and history of previous stroke were excluded from
the study. A structured questionnaire as appended was used
to collect information on demographic variables, stroke
severity (with the help of modified Rankin Scale [mRS]
and National Institute of Health Stroke Scale [NIHSS]),
stroke subtype using TOAST criteria, vascular risk factors,
and stroke workup. Patients were labeled as hypertensive if
systolic blood pressure was greater than 140mmHg or/and
diastolic blood pressure was greater than 90mmHg during
repeated measurements during the patient management in
the hospital or if the patient was on antihypertensive drugs at
the time of admission.We classified patient as diabetic if self-
reported fasting glucose level of the patient was 120mg/dL
or more or if the patient was on hypoglycemic agents or
insulin. Patients having serumhigh density lipid of 100mg/dL
or less and/or serum low density lipid of 100mg/dL or more
and/or fasting serum cholesterol of 200mg/dL or more were
labeled as having dyslipidemia. Smokers were the patients
who had smoked ten or more cigarettes for ten or more years.
Electrocardiogram was used to check for atrial fibrillation.
Carotid Doppler was used to identify patients having carotid
stenosis. Left ventricular dysfunction was assessed using
echocardiogram. Patients having 30% or less ejection fraction
were classified as having severe left ventricular dysfunction.
Patients or their next of kin were briefed about the pur-
pose and nature of the study. Written consent was obtained
from the patients or their next of kin in case of incapacitation
of the patients. Ethical approval was obtained from Ethical
Review Committee of Bangladesh Diabetic Association, the
parent body that runs BIRDEM General Hospital.
Upon receipt of the consent of the patients or their
nearest relative’s consent qualified medical personnel, not
below senior medical officer and assistant register, examined
and interviewed the patient or the patient’s attendant about
past medical and personal history and recorded the variable
of interest. Investigations, ECG, CT scan, MRI, echocar-
diography, and carotid Doppler, only pertinent to clinical
presentations, were advised. Standardized Data Collection
Form was used in recruiting patients.
On discharge patients or their attendants were asked to
report the BIRDEM neurology clinic after four weeks and
then after six months. Assigned medical personnel were in
contact to follow the progress over telephone in the four
weeks.
Data were managed using Statistical Package for Social
Science (SPSS) for Windows Version 19. In the presentation
data were expressed as mean ± SD, median (minimum-
maximum), and number (percent) as appropriate. Unpaired
Student’s 𝑡-test, proportion test, and Chi-squared tests were
performed, where applicable, to calculate statistical difference
between corresponding groups and/or association between
groups. 𝑃 value <0.05 was taken as level of significance.
Logistic regression was used to compute adjusted odds ratio
for poor outcomes of stroke. Linear regression was done to
identify variables explaining Barthel score.
3. Sample Size
Sample size was calculated using OpenEpi, Version using
formula [DEFF∗𝑁𝑝(1−𝑝)]/[𝑑2/𝑍2
1−𝛼/2
∗(𝑁−1)+𝑝∗(1−𝑝)].
Using this formula we planned to recruit a minimum of 600
stroke patients to capture the anticipated prevalence of stroke
risk factors to be 50% among the stroke patients, margin of
error to be 4%, and level of significance to be 5%.
4. Results
This stroke registry gathered data from 679 stroke patients
in BIRDEMGeneral Hospital, Dhaka, Bangladesh. Mean age
of the stroke patients was 60.6 years; the majority of patients
(67.7%) were male. Only 16.5% of the patients had age greater
than 70 years.Most patients (66%) had an age between 45 and
70 years. Only 72 (11%) patients (50men and 22 women) were
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Table 1: Known risk factors (𝑛 = 679).
Risk factors 𝑛 (%)
Diabetes 506 (74.5)
Hypertension 504 (74.2)
Dyslipidemia 48 (7.1)
IHD 81 (11.9)
Current smoker 𝑛 = 629 110 (17.5)
Past smoker 𝑛 = 629 82 (13.0)
Chewing tobacco 191 (28.1)
Family history of stroke 𝑛 = 644 193 (30.0)
Family history of IHD 𝑛 = 644 134 (20.8)
Atrial fibrillation 8 (1.2)
HDL ≤ 40 (614) 433 (70.5)
LDL > 100 (608) 420 (69.1)
Total cholesterol > 200 (615) 264 (42.9)
Dyslipidemia (chol > 200 or LDL > 100
or HDL < 40) (614) 571 (93)
In-hospital complications
DVT 2 (0.3)
Pneumonia 60 (8.8)
UTI 54 (8.0)
Pulmonary edema 1 (0.1)
Phlebitis/cellulitis 6 (0.9)
Sepsis 6 (0.9)
Hematuria 2 (0.3)
Seizers 26 (3.8)
Deep venous thrombosis: DVT, ischemic heart disease: IHD, high density
lipoprotein: HDL, low density lipoprotein: LDL, and urinary tract infection:
UTI.
less than 45 years. Diabetes, hypertension, family history of
stroke, and ischemic heart disease were common risk factors
identified at the time of admission (Table 1).
Small vessel strokes were the most common accounting
for 45.4% of all the patients followed by large vessel stroke in
32.5% of the cases. Cardioembolic stroke was present in 4.9%
while etiology was not defined in 17.2% of the stroke cases.
Out of a total 673 patient among whom NIHSS score was
recorded 121 patients (17.8%) had severe stroke (NIHSS score
greater than 14). Dyslipidemia was present in 93% of the cases
(Table 1). Most common infarct location was in parietal lobe
found in 236 (34.8%), followed by basal ganglia in 184 (27.1%)
and internal capsule 178 (26.2%), of the patients (Table 2).
ECG was done for all the patients and there was cardiac
morbidity on ECG in 50.2% of these patients. Ischemia was
the most common cardiac abnormality detected on ECG
and was present in 28.1% of the patients. Other cardiac
abnormalities detected on ECG included left ventricular
hypertrophy (6.3%), old infarct (5.4%), left bundle branch
block (4.1%), left atrial dilation (3.7%), atrial fibrillation
(1.2%), and right bundle branch block (0.9%). Pneumonia
was the most common complication found in 60 (8.8%)
subjects while UTI was found in 54 (8.0%) subjects (Table 1).
Table 2: Infarct location (𝑛 = 679).
Location of infarct 𝑛 (%)
Front 38 (5.6)
Parietal 236 (34.8)
Temporal 39 (5.7)
Occipital 34 (5.0)
Basal ganglia 184 (27.1)
Thalamus 45 (6.6)
Subcortical 6 (0.9)
Internal capsule 178 (26.2)
Midbrain 16 (2.4)
Pons 41 (6.0)
Medulla 12 (1.8)
Cerebellar 47 (6.9)
Mean stay in hospital was 7.8 days (standard deviation,
3.9). All the patients were assessed for their outcomes using
mRS (modified Rankin Scale) score at discharge from hospi-
tal. Only 16 (2.4%) of the died during treatment, 436 (64.2%)
patients had their mRS score from 3 to 5 (moderate to severe
disability) while 227 (33.4%) of the patients had anmRS score
equal to or less than 2 (no to mild disability).
By comparing gender it was shown that higher proportion
of females had hypertension. Smoking and UTI were more
common among males. Women had a slightly greater mean
hospital stay.Moremales had favorable outcome on discharge
as compared to females (Table 3).
Individuals with age less than or equal to 45 years had
a higher proportion of diastolic blood pressure and carotid
stenosis while UTI and pneumonia were more commonly
found in patients with age greater than 45 years (Table 4).
Elderly patients (age > 70 years) were more likely to
have pneumonia, severe left ventricular dysfunction, and
hypertension. More patients in the age group less than or
equal to 70 had diastolic blood pressure, diabetes mellitus,
and smoking. More patients in this group had favorable
outcomes at discharge (mRS on discharge 0 to 2) (Table 5).
Odds of poor outcome on discharge were for those who
had an age greater than 70 years being 1.79 (95% CI: 1.05
to 3.06) as compared to those having an age less than or
equal to 70 years when adjusted for gender, number of
days of hospital stay, HDL, and pneumonia. On the basis of
linear regression factors explaining Barthel score there were
mRS, age, systolic blood pressure, urinary tract infection,
pneumonia, and stroke severity (Table 6).
5. Discussion
To the best of our knowledge this is the first registry which
intended to collect data on a wide range of stroke patients
from a tertiary care center in Bangladesh. There are certain
limitations as this registry was maintained only in one center.
There were missing data on some of the variables. Same
set of investigations could not be performed on all the
patients. We were unable to follow up the patients after
discharge and therefore we could not find out the mortality
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Table 3: Risk factors of stroke patient by gender.
Variable Male 𝑛 = 460 Female 𝑛 = 219 𝑃 value
Age mean (SD) 60.32 (11.0) 61.24 (11.0) 0.31
Systolic BP mean (SD) 144.22 (22.7) 144.59 (21.7) 0.84
Diastolic BP mean (SD) 84.79 (12.1) 84.31 (12.3) 0.63
RBS mean (SD) 231.48 (95.1) 231.23 (94.5) 0.98
TOAST 𝑛 (%)
Large vessel 148 (32.2) 73 (33.3)
0.81Small vessel 214 (46.5) 94 (42.9)
Cardioembolic 21 (4.6) 12 (5.5)
Unknown etiology 77 (16.7) 40 (18.3)
Risk factors
DM (RBS > 200) 237 (57.8) 118 (60.5) 0.53
HTN 323 (70.2) 181 (82.6) 0.01
Dyslipidemia 392 (94.2) 179 (90.4) 0.08
Smoking 106 (24.4) 4 (2.1) <0.01
Carotid stenosis > 70% 17 (15.7) 11 (17.7) 0.74
A-fib on ECG 5 (1.1) 3 (1.4) 0.72
Severe LV dysfunction 62 (17.9) 25 (15.1) 0.42
Investigations
MRI 100 (21.7) 40 (18.3) 0.30
Echocardiography 299 (78.5) 145 (80.1) 0.66
Carotid Doppler 374 (81.3) 174 (79.5) 0.57
Complications
Pneumonia 36 (7.8) 24 (11.0) 0.18
UTI 26 (39.3) 32 (18.7) <0.01
Stroke severity NIHSS > 14 79 (17.2) 42 (19.2) 0.52
mRs at discharge
0–2 170 (37.0) 57 (26.0)
0.023–5 279 (60.7) 157 (71.7)
6 11 (2.4) 5 (2.3)
Hospital mean stay 7.5 (3.7) 8.5 (4.2) <0.01
Atrial fibrillation: A-fib, blood pressure: BP, diabetes mellitus: DM, elec-
trocardiogram: ECG, hypertension: HTN, left ventricular: LV, magnetic
resonance imaging: MRI, National Institute of Health Stroke Scale: NIHSS,
random blood sugar: RBS, standard deviation: SD, and urinary tract
infection: UTI.
rate of these patients for standard time period. Despite these
limitations this data provides useful information related to
stroke types/subtypes, risk factors, gender, and age of stroke
onset based differences among stroke patients enrolled at this
large center inDhaka, Bangladesh.This is probably the largest
data set of stroke patients published from Bangladesh.
Mean age of the stroke patients which is around sixty
years is consistent with findings from a similar stroke registry
in Pakistan [20]. Most of the patients from a stroke registry in
USA presented with stroke at an age of 71 years [21]. In Korea
the mean age of patients getting registered is around 62 years
[22]. In our sample the mean age of stroke patient was not
affected by gender while stroke registry from France showed
that mean age for female stroke patients was 70 years while it
was 66 years for male patients [23].
The lower percentage of female stroke patients being
registered implies either a low prevalence of stroke among
Table 4: Distribution of covariates among stroke patients with
young age.
Variable ≤45 yrs,
𝑛 = 72
>45 yrs,
𝑛 = 607
𝑃 value
Systolic BP mean (SD) 143.3 (21.8) 144.5 (22.4) 0.67
Diastolic BP mean (SD) 88.7 (13.5) 84.2 (11.9) <0.01
RBS mean (SD) 246.6 (104.0) 229.7 (93.7) 0.19
TOAST 𝑛 (%)
Large vessel 25 (34.7) 196 (32.3)
0.89Small vessel 30 (41.7) 278 (45.8)
Cardioembolic 3 (4.2) 30 (4.9)
Unknown etiology 14 (19.4) 103 (17.0)
Stroke severity NIHSS 9.1 (5.4) 9.5 (5.5) 0.57
Risk factors
DM (RBS > 200) 54 (75.0) 452 (74.5) 0.92
HTN 51 (70.8) 453 (74.6) 0.49
Dyslipidemia 60 (92.3) 511 (93.1) 0.82
Smoking 14 (19.4) 96 (15.8) 0.43
Carotid stenosis > 70% 5 (38.5) 23 (14.6) 0.03
A-fib on ECG 1 (1.4) 7 (1.2) 0.86
Severe LV dysfunction 12 (22.6) 75 (16.3) 0.25
Investigations
MRI 18 (25.0) 122 (20.1) 0.33
Echocardiography 49 (77.8) 395 (79.2) 0.80
Carotid Doppler 51 (70.8) 446 (73.5) 0.63
Complications
Pneumonia 2 (2.8) 58 (9.6) 0.06
UTI 1 (1.4) 57 (9.4) 0.02
mRs at discharge
0–2 28 (38.9) 199 (32.8)
0.553–5 42 (58.3) 394 (64.9)
6 2 (2.8) 14 (2.3)
Hospital mean stay 7.2 (3.4) 7.9 (3.9) 0.19
Atrial fibrillation: A-fib, blood pressure: BP, diabetes mellitus: DM, elec-
trocardiogram: ECG, hypertension: HTN, left ventricular: LV, magnetic
resonance imaging: MRI, National Institute of Health Stroke Scale: NIHSS,
random blood sugar: RBS, standard deviation: SD, and urinary tract
infection: UTI.
females or a lower access of female stroke patients to the
tertiary care hospital. Paradoxically length of hospital stay
and stroke severity on discharge were higher among females.
We found that though a very small number ofwomen smoked
which implies that smoking cessation programs should also
target females. We cannot rule out underreporting of smok-
ing among females due to cultural reasons.These findings are
consistent with previous reports that frequency of stroke in
Asian women is less than Asian men but may be higher than
European man and women both [24].
In this sample atherosclerosis in the small vessel was
responsible for most of the stroke cases. Majority of these
patients had dyslipidemia. Hypertension and diabetes were
other risk factors that were present in them. Inclusion of large
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Table 5: Distribution of covariates among stroke patients in old age.
Variable ≤70 yrs,
𝑛 = 567
>70 yrs,
𝑛 = 112
𝑃 value
Male 𝑛 (%) 385 (67.9) 75 (67.0) 0.85
Systolic BP mean (SD) 144.9 (22.5) 141.7 (21.4) 0.17
Diastolic BP mean (SD) 85.2 (12.3) 81.7 (10.9) <0.01
RBS mean (SD) 232.8 (97.6) 224.3 (79.3) 0.35
TOAST 𝑛 (%)
Large vessel 182 (32.1) 39 (34.8)
0.15Small vessel 267 (47.1) 41 (36.6)
Cardioembolic 27 (4.8) 6 (5.4)
Unknown etiology 91 (16.0) 26 (23.2)
Risk factors 𝑛 (%)
DM (RBS > 200) 436 (76.9) 70 (62.5) <0.01
HTN 412 (72.7) 92 (82.1) 0.04
Dyslipidemia 479 (93.6) 92 (90.2) 0.23
Smoking 98 (17.3) 12 (10.7) 0.09
Carotid stenosis > 70% 24 (18.9) 4 (9.3) 0.14
A-fib on ECG 7 (1.2) 1 (0.9) 0.76
Severe LV dysfunction 259 (58.3) 60 (68.2) 0.09
Investigations
MRI 124 (21.9) 16 (14.3) 0.07
Echocardiography 373 (79.7) 71 (75.5) 0.37
Carotid Doppler 413 (72.8) 84 (75.0) 0.64
Complications
Pneumonia 43 (7.6) 17 (15.2) 0.01
UTI 47 (8.3) 11 (9.8) 0.60
Stroke severity NIHSS > 14 78 (13.9) 20 (17.9) 0.29
mRs at discharge
0–2 200 (35.3) 27 (24.1)
0.073–5 354 (62.4) 82 (73.2)
6 13 (2.3) 3 (2.7)
Hospital mean stay 7.9 (3.9) 7.6 (4.0) 0.54
Atrial fibrillation: A-fib, blood pressure: BP, diabetes mellitus: DM, elec-
trocardiogram: ECG, hypertension: HTN, left ventricular: LV, magnetic
resonance imaging: MRI, National Institute of Health Stroke Scale: NIHSS,
random blood sugar: RBS, standard deviation: SD, and urinary tract
infection: UTI.
number of patients with diabetesmay be explained by the fact
of the recruitment fromBIRDEMGeneral Hospital, a tertiary
care hospital run by the Diabetic Association of Bangladesh,
only which, however, is 650-bed multidisciplinary hospital.
Diabetes was more common among the age group less than
or equal to seventy years. Dyslipidemia, hypertension, and
diabetes are important risk factors for stroke as reported
previously [19, 25, 26]. We found that a very high proportion
of the stroke patients (93%) had dyslipidemia as compared to
Pakistan [20, 26]. Similarly other two important risk factors,
that is, diabetes and hypertension, are more common among
stroke patients in Bangladesh as compared to Pakistan.
Mortality of the stroke patient was much lower as com-
pared to regional data [20]. This lower mortality can be
because of better access to the tertiary care hospitals, better
clinical care of the patients, or a combination of the two. An
alternative explanation may be that only patients with lesser
stroke severity and better prognosis reach to the hospitals. A
study designed to specifically answer this uncertainty may be
helpful to explore factors responsible for the lower mortality.
Burden of stroke is growing in large parts of Asia due to
growing age, urbanization, and life style changes. No data
is available from Bangladesh related to temporal trends in
stroke incidence or stroke types. It is important to follow these
trends for future analysis and interventions [27].
This study gives us some critical insight into important
aspects of stroke patients in Bangladesh. It is important to
make stroke risk scoring tools for this population with the
help of the risk factors identified in this study. Stratification
of the population with the help of these tools into high,
intermediate, and low risk group may help public health
practitioners to prevent stroke. It is important to generate
contextual evidence for designing composite interventions on
the basis of behavior change communication theories for the
primary prevention of stroke in this population. Population
based studies looking at incidence and prevalence of stroke
are much needed. Most studies related to Bangladesh are
limited to one or few centers. Large, multicenter studies with
nationally representative distribution pattern are required to
plan community/population based interventions.
Appendix
A. Questionnaire
Name: [ ]
Ethnicity:
Age: [ ]
Sex:
◻ M
◻ F
Ph no: [ ]
Add: [ ]
Admission date/time: / / : PM/AM
Education:
◻ Illiterate
◻ Class 1–5
◻ Matric or less intermediate
◻ graduate
◻ Post graduate
Meds on adm:
◻ Aspirin
◻ Persantin
◻ Ticlid
◻ Warfarin
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Table 6: Results of multiple linear regression with Barthel score as the outcome.
Variable Coefficient (𝛽) Standard error (SE) 95% CI 𝑃 value
Intercept 78.00 5.67
mRS (4 or above) −30.11 1.50 −33.01 to −27.20 <0.01
Age −0.17 0.06 −0.29 to −0.06 <0.01
Systolic blood pressure −0.07 0.03 −0.12 to −0.01 0.03
UTI −6.08 2.43 −10.85 to −1.30 0.01
Pneumonia −9.64 2.42 −14.39 to −4.90 <0.01
Stroke severity NIHSS > 14 −20.86 1.95 −24.69 to −17.03 <0.01
Urinary tract infection: UTI.
◻ Plavix
◻ AntiHTN
◻ Antilipid
◻ oral hypoglycemic
◻ insulin
◻ Others
◻ NONE
Blood Pressure At arrival (mmHg): / .
Temp: at arrival: ∘C
Pulse at arrival (beats per minute):
stroke onset:
◻ awake (Time: am/pm)
◻ asleep
(If stroke occurs during sleep onset time will be when
person retires to bed)
Exact Time (in hours and minutes) between stroke
onset and presentation: hrs min
Assoc diagnosis on history:
◻ DM
◻ HTN
◻ Dyslipidemia
◻ IHD
◻ MI
◻ A. fib
◻ h/o RHD
Prosthetic valve (which valve? ) dura-
tion
Smoking status:
◻ Smoker # pack/year [ ]
◻ Ex smoker # of years left smoking [ ]
◻ Non smoker
Tobacco use:
◻ chewing tobacco
◻ shisha/huqqa
◻ other form of tobacco;
Alcohol abuse;
current history of alcoholism
Previous stroke:
◻ Y
◻ N
(hemmorhagic ischemic Unknown).
If Yes; # of strokes ( )
Previous TIA:
◻ Y
◻ N
If Yes; # of TIA ( )
If DM or HTN:
Retinopathy
◻ Y
◻ N
Proteinuria
◻ Y
◻ N
↑ Creatinine
◻ Y
◻ N
(value) [ ]
Family history:
F/H of Stroke in 1∘ relative:
◻ Y
◻ N
F/H of IHD in 1∘ relative:
◻ Y
◻ N
Stroke Severity at Admission
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NIHSS score [ ]
Rankin:
on Adm
◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
Rankin:
@ baseline
◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
(Before stroke onset)
Please mention “not done” if any test is not performed, against
the entry
Imaging:
first imaging: normal:
◻ Y
◻ N
CT Scan or MRI (Circle one)
If Ist image abnormal:
◻ Intraparenchymal hemorrhage
◻ Intraventricular hemorrhage
◻ Established infarct
◻ Early infarct (Circle one)
If >1 infarct: Number of infarct [ ]
Periventricular ischemic changes
◻ Y
◻ N
Old infarcts:
◻ Y
◻ N
(Number of infarcts )
Subsequent imaging: normal:
◻ Y
◻ N
CT Scan or MRI or both (Circle one)
MRI
date/time:
Findings [ ]
Intraparenchymal hemorrhage
Intraventricular hemorrhage
volume
New infarct’s Size (cm × cm) [ ]
CT
date/time:
Findings [ ]
Intraparenchymal hemorrhage
Intraventricular hemorrhage
volume
New infarct’s Size (cm × cm) [ ]
Old infarcts
number
location
MRA
date/time:
◻ Normal
◻ Abnormal
◻ Variant
If variant:
◻ hypoplastic ACA
◻ ACAs filling from one side
◻ absent vertebral
◻ small/hypoplastic
◻ vertebral
◻ PCAfilling through PCom
diffuse atherosclerodis in MRA:
◻ ant circ
◻ post circ
◻ both
focal stenosis of specific region in MRA:
◻ Y
◻ N
region [ ]
focal occlusion of specific region in MRA:
◻ Y
◻ N
region [ ]
Hemorrhagic Conversion:
◻ Y
◻ N
Mass effect:
◻ Y
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◻ N
Midline shift
◻ Y
◻ N
[ ] mm
Imaging Findings (New Stroke)
Vascular teretories (can be more than one response):
◻ ant cerebral
◻ middle cerebral
◻ Watershed
◻ Vertebrobasilar posterior cerebral
Location of infarct or hemorrhage:
◻ Right frontal
◻ Left Frontal
◻ Right Parietal
◻ Left Parietal
◻ Right Temporal
◻ Left Temporal
◻ Right Occipital
◻ Left Occipital
◻ Right basal ganglia
◻ Left Basal Ganglia
◻ Right Thalamus
◻ LeftThalamus
◻ Right Internal capsule
◻ Left Internal Capsule
◻ Right subcortical
◻ Left Subcortical
◻ Right Midbrain
◻ Left Midbrain
◻ Right Pons
◻ Left Pons
◻ Right Medulla
◻ Left Medulla
◻ Right Cerebellar hemisphere
◻ Left Cerebellar Hemishere
◻ Vermis
Workup
CXR
◻ nl
◻ pneum cardiomeg
◻ pulm edema
◻ effusion
◻ other (specify):
EKG
◻ nl
◻ new Infarct
◻ old infarct
◻ Ischemia
◻ BBB (LBBB/RBBB)
◻ A fib
◻ LAD
◻ LVH Other (specify):
(Specify location/region of infarct)
Blood sugar at admission (mg/dL):
Troponin:
◻ Normal
◻ Elevated
Hb/Hct:
Red cell count:
TLC/DLC:
Platelet:
Hemoglobin;
lipids [Total Chol: Triglyc: TL: HDL:
LDL: ]
Hypercoag state:
◻ Y
◻ N
◻ not assessed
protein C ( %),
protein S ( %),
antithrombin III ( )
PT/INR ( )
Aptt ( )
Serum Homocysteine level ( )
Factor VIII level ( )
Antiphospholipid AB:
◻ +ve
◻ −ve
◻ Not done
Transthoracic Echo or transthoracic echo (Circle):
◻ done
◻ not done
left vent wall motion abnormalties
◻ Y
◻ N
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left vent systolic function
◻ severe ef < 35%
◻ moderate ef 35–50%
◻ mild ef 50–55%
◻ normal
Ejection fr [ ]%
Thrombus
◻ Y
◻ N
location [ ]
Valvular disease
◻ Y
◻ N
◻ mit sten
◻ mit regurg
◻ mit prol
◻ aort
◻ other [ ]
Atrial dilat
◻ Y
◻ N
◻ Left
◻ Right
◻ both
LVH:
◻ Y
◻ N
LVDD:
◻ Y
◻ N
Vent dilat
◻ Y
◻ N
◻ Left
◻ Right
◻ Both
R-L shunt
◻ Y
◻ N
PFO
◻ Y
◻ N
ASD
◻ Y
◻ N
Abnormalities in arch of aorta (Specify):
Carotid Doppler:
◻ Nl
◻ Abnl
◻ not done
R int crtd plaq
◻ Y
◻ N
◻ Ulcerated
◻ Calcified
◻ Both
◻ Neither% stenosis [ % ]
L int crtd plaq
◻ Y
◻ N
◻ Ulcerated
◻ Calcified
◻ Both
◻ Neither% stenosis [ % ]
ANY OTHERWORK UP:
Hospital Course
Received tPA
◻ Y
◻ N
(Reason )
Complications/Events:
◻ DVT
◻ Pneumonia
◻ UTI
◻ GI hem
◻ Bedsore
◻ Stroke
◻ TIA
◻ Angina
◻ MI
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◻ CCF/pulmonary edema
◻ cardiogenic shock
◻ phlebitis/cellulitis
◻ sepsis
◻ hematuria
◻ PEG insertion
◻ NG
◻ tube
◻ Foleys Catheter Mech:
◻ ventilation
◻ seizures
◻ Heparinized/anticoagulated (if yes indication
)
◻ Surgery
◻ Death
◻ Other [ ]
◻ NONE
Discharge
Diagnosis;
◻ Ischemic stroke
◻ Hemorrhagic stroke
Discharge Diagnosis on TOAST criteria (for ischemic
stroke):
◻ Large vsl thrombotic
◻ Small vsl thrombotic
◻ Cardioemb
◻ Unknown or ill-defined etiology
◻ Other definite etiology (Specify )
◻ Cerebral venous thrombosis
New diagnosis:
◻ HTN
◻ DM
◻ Dyslipidemia
◻ CAD
Hospital stay: [ ] days
Stroke Severity at Discharge
NIHSS: [ ]
Rankin (MRS):
◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
Medications at discharge:
◻ ASA
◻ Warf
◻ Perstn Ticlid
◻ ASA + Prstn
◻ Plavix
(Specify drugs on the following)
◻ Anti HTN
◻ Antilipid
◻ oral hypoglycemic
◻ insulin antibiotics
◻ Other [ ]
Disposition:
◻ Home Hospital
◻ Nursing facility
◻ Expired
◻ Other [ ]
30 day follow up:
Rankin (MRS):
◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
Recurrent stroke
yes/no
6 months follow up
Rankin (MRS):
◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
Recurrent stroke
yes/no
One year follow up:
Rankin (MRS):
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◻ 0
◻ 1
◻ 2
◻ 3
◻ 4
◻ 5
◻ 6
Recurrent stroke
yes/no
B. National Institutes of Health Stroke Scale
Level of Consciousness:
0 = Alert
1 = Not alert, but arousable with minimal stim-
ulation
2 = Not alert, requires repeated stimulation to
attend
3 = Coma
Questions (ask patient the Month and their age)
0 = Answers both correctly
1 = Answers one correctly
2 = Answers neither correctly
Commands (Ask patient {1} to open and close eyes and
{2}make fist)
0 = Performs both tasks correctly
1 = Performs one task correctly
2 = Performs neither task
Gaze (only horizontal gaze)
0 = Normal
1 = Partial gaze palsy
2 = Total gaze palsy
Visual fields
0 = No visual loss
1 = Partial hemianopsia
2 = Complete hemianopsia
3 = Bilateral; hemianopsia
Facial Palsy
0 = Normal
1 = Minor paralysis
2 = Partial paralysis
3 = Complete paralysis
Motor arm (score each arm separately)
0 = No drift (Able to keep arm extended at 90∘
while sitting or 45∘ while lying, with out drift for
10 seconds)
1 = Drift before five seconds
2 = Fall before ten seconds
3 = No effort against gravity
4 = No movement
Motor leg (score each leg separately)
0 =No drift (Able to keep leg extended at 30∘ with
out drift for 10 seconds)
1 = Drift before five seconds
2 = Fall before ten seconds
3 = No effort against gravity
4 = No movement
Ataxia
0 = Absent, no ataxia
1 = One limb
2 = Two limbs
Sensory
0 = Normal
1 = Mild loss
2 = Severe loss
Language
0 = Normal
1 = Mild Aphasia
2 = Severe aphasia
3 = Mute or global aphasia
Dysarthria
0 = Normal
1 = Mild
2 = Severe
11=Extinction and inattention
0 = Normal
1 = Mild
2 = Severe
Modified Rankin Scale
Grade 0; Normal
Grade 1; Minor symptoms without disability, able to
perform prior activities
Grade 2; Slightly disabled but can walk and do self
care without assistance
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Grade 3; Moderately disabled, needing some help but
can walk unaided
Grade 4;Moderate to severe disability, unable to walk,
needing some help in ADL
Grade 5: Severly disabled, bedridden, requiring con-
stant care
Grade 6: Death
Barthel Index
Feeding
0 = unable
5 = needs help cutting, spreading butter, and so
forth, or requires modified diet
10 = independent
Bathing
0 = dependent
5 = independent (or in shower)
Grooming
0 = needs to help with personal care
5 = independent face/hair/teeth/shaving (imple-
ments provided)
Dressing
0 = dependent
5 = needs help but can do about half unaided
10 = independent (including buttons, zips, laces,
etc.)
Bowels
0 = incontinent (or needs to be given enemas)
5 = occasional accident
10 = continent
Bladder
0 = incontinent, or catheterized and unable to
manage alone
5 = occasional accident
10 = continent
Toilet Use
0 = dependent
5 =needs somehelp, but can do something alone
10 = independent (on and off, dressing, wiping)
Transfers (bed to chair, and back)
0 = unable, no sitting balance
5 =major help (one or two people, physical), can
sit
10 = minor help (verbal or physical)
15 = independent
Mobility (on level surfaces)
0 = immobile or <50 yards
5 = wheelchair independent, including corners,
>50 yards
10 = walks with help of one person (verbal or
physical) >50 yards
15 = independent (but may use any aid; e.g.,
stick) >50 yards
Stairs
0 = unable
5 = needs help (verbal, physical, carrying aid)
10 = independent
TOTAL (0–100):
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